UMass Chan Receives $1.6M Grant for Safer Gene Therapy Delivery Research
UMass Chan Medical School has been awarded a $1.6 million grant from the National Institute of General Medical Sciences to enhance the safety of gene therapy delivery methods. The research, led by Phillip Tai, focuses on improving adeno-associated viral vectors, which are commonly used in gene therapy to deliver genetic material into cells. The study aims to reduce the potential risks associated with these vectors, such as the inadvertent integration of genetic material into a patient's DNA, which could lead to cancer. 
